Lisinopril Cost in North Dakota (2026): Cash Prices, Insurance, and Savings

Prescription access and medication affordability image for Lisinopril Cost in North Dakota (2026): Cash Prices, Insurance, and Savings

At a glance

  • Average ND retail cash price / $8 per month (generic, 2026)
  • Manufacturer list price / $50 per month
  • Lowest available price / $4 per month with discount card
  • ND Medicaid status / Not on preferred drug list
  • Commercial insurance tier / Typically Tier 1 (lowest copay)
  • 503A compounding / Legal in North Dakota
  • Telehealth prescribing / Permitted statewide
  • Standard dosing / 10 to 40 mg once daily oral tablet
  • FDA-approved indications / Hypertension, heart failure, post-MI survival
  • Patent status / Off-patent since 2002; multiple generic manufacturers

What Does Lisinopril Cost at North Dakota Pharmacies in 2026?

Generic lisinopril is one of the least expensive prescription medications available at North Dakota pharmacies, averaging $8 per month for a 30-day supply of 10 mg or 20 mg tablets. The manufacturer list price sits around $50, but virtually no patient pays that figure because generic competition has driven actual transaction prices far below it.

Prices vary by pharmacy and city. In Fargo and Bismarck, large chain pharmacies (Walmart, Walgreens, CVS) typically offer 30-tablet supplies between $4 and $10. Independent pharmacies in smaller communities like Minot, Williston, and Grand Forks tend to price within the same band, though occasional markups push costs to $12, $15 at locations with limited generic inventory. Lisinopril is an ACE inhibitor first approved by the FDA in 1987 and has remained a first-line antihypertensive for nearly four decades. The 2017 ACC/AHA Hypertension Guideline recommends ACE inhibitors as one of four preferred first-line drug classes for stage 1 hypertension. Patients filling lisinopril without insurance should request the pharmacy's generic cash price and compare it against discount card pricing before paying.

Why Is Lisinopril So Affordable in North Dakota?

The drug's low cost reflects market dynamics, not a lack of efficacy. Lisinopril lost patent exclusivity in 2002, and today more than a dozen generic manufacturers compete for market share.

That competition benefits North Dakota patients directly. The state's pharmacy market includes both national chains participating in $4 generic programs and independent pharmacies that match or undercut those prices to retain customers. According to an analysis of generic drug pricing trends published in JAMA Internal Medicine, generic ACE inhibitor prices fell by over 70% between 2005 and 2015, and they have remained flat or declined further since then. The ALLHAT trial (N=33,357), the largest antihypertensive comparison study ever conducted, demonstrated that the thiazide diuretic chlorthalidone performed comparably to lisinopril and amlodipine across most endpoints, which means all three drug classes are viable first-line options. That broad therapeutic substitutability keeps pricing competitive across the entire antihypertensive generic market. North Dakota's low population density does not inflate lisinopril prices because the drug is shelf-stable, lightweight, and shipped easily to rural pharmacies at minimal additional cost.

Does North Dakota Medicaid Cover Lisinopril?

North Dakota Medicaid does not list lisinopril on its preferred drug list as of 2026. This does not mean Medicaid beneficiaries cannot access the drug, but it does mean they may need prior authorization or face higher cost-sharing compared to preferred alternatives.

North Dakota Medicaid administers its pharmacy benefit through a managed formulary. Preferred ACE inhibitors on the state's formulary may include other generics in the same class. Prescribers can submit a prior authorization request when lisinopril is clinically preferred, citing the ACC/AHA guideline recommendation or patient-specific factors such as prior titration history. Approval rates for generic ACE inhibitor prior authorizations tend to be high because the per-unit cost difference between agents is minimal. For Medicaid-eligible patients in North Dakota, the practical path is straightforward: ask the prescriber to check the current preferred drug list, try the preferred agent first if clinically equivalent, and request prior authorization for lisinopril if it is not. Given that the cash price is $4, $8, some Medicaid patients find it simpler to pay out of pocket rather than manage prior authorization.

Which Commercial Insurance Plans Cover Lisinopril in ND?

Nearly every commercial insurance plan available in North Dakota covers generic lisinopril at Tier 1, the lowest copay tier. This includes plans offered through Blue Cross Blue Shield of North Dakota, Sanford Health Plan, Medica, and marketplace plans sold on HealthCare.gov.

Tier 1 copays in North Dakota typically range from $0 to $10 for a 30-day supply. Many high-deductible health plans (HDHPs) paired with health savings accounts require patients to pay the full negotiated rate until meeting their deductible, but even then, the negotiated rate for lisinopril rarely exceeds $6, $8. A study in Circulation found that reducing copays for cardiovascular medications improved adherence by 4 to 6 percentage points, underscoring why insurers keep ACE inhibitors at the lowest tier. Patients enrolled in Medicare Part D plans in North Dakota similarly find lisinopril on Tier 1. The Medicare Part D formulary requirements mandate coverage of at least one ACE inhibitor, and most plans cover several, including lisinopril. For patients with any form of insurance, the copay for lisinopril will almost always be lower than the cash price, making insurance the default cost-saving route.

How Do Discount Cards and Savings Programs Work in North Dakota?

Discount programs like GoodRx, RxSaver, and SingleCare can reduce generic lisinopril to $4 or less at participating North Dakota pharmacies. These are not insurance. They are negotiated rate cards.

The mechanism is simple: discount platforms negotiate group purchasing rates with pharmacy benefit managers, then pass those rates to consumers who present a card or coupon at the pharmacy counter. A 30-day supply of lisinopril 10 mg or 20 mg consistently prices at $3, $5 through these programs at Walmart, Walgreens, and CVS locations in Fargo, Bismarck, and Minot. Research published in Annals of Internal Medicine found that prescription discount programs offered lower prices than insurance copays for generic drugs in 6 to 12% of transactions, making them a useful backup even for insured patients. The $4 generic programs at Walmart and similar retailers also cover lisinopril at all North Dakota locations. These programs require no enrollment fee and no income verification. Patients simply need a valid prescription.

Is Compounded Lisinopril Legal in North Dakota?

Yes. North Dakota permits 503A compounding pharmacies to prepare lisinopril formulations. This is relevant primarily for patients who need non-standard dosage forms, such as oral suspensions for pediatric dosing or patients with swallowing difficulties.

Section 503A of the Federal Food, Drug, and Cosmetic Act allows licensed pharmacies to compound patient-specific prescriptions based on a valid prescriber order. North Dakota's Board of Pharmacy regulates 503A pharmacies within the state under these federal rules. Compounded lisinopril is not typically cheaper than commercially manufactured generic tablets. In fact, compounded preparations may cost more due to the labor involved in custom formulation. The clinical niche for compounded lisinopril is narrow: ACC/AHA guidelines do not specifically recommend compounded over manufactured formulations, and the FDA-approved oral tablet is the standard. Patients considering compounded lisinopril should confirm with their prescriber that a commercially available form (tablets in 2.5 mg, 5 mg, 10 mg, 20 mg, and 40 mg strengths) cannot meet their needs before pursuing compounding.

Can You Get Lisinopril via Telehealth in North Dakota?

North Dakota permits telehealth prescribing of lisinopril statewide. A provider licensed in North Dakota can evaluate a patient via video or audio visit and prescribe lisinopril without an in-person examination.

The North Dakota Board of Medicine adopted telehealth practice standards consistent with post-2020 expanded access policies. Lisinopril prescribing via telehealth follows the same clinical protocols as in-person visits: blood pressure measurement (often via home monitoring devices), assessment of renal function through serum creatinine and potassium levels, and discussion of contraindications including pregnancy and bilateral renal artery stenosis. Telehealth platforms operating in North Dakota include both national services and regional health system portals through Sanford Health and Altru Health System. The typical telehealth visit cost ranges from $20 to $75 without insurance, making the total cost of a telehealth visit plus a 30-day lisinopril supply as low as $24, $83. For patients in rural areas of western North Dakota, where the nearest primary care office may be 60 miles away, telehealth access to a straightforward antihypertensive like lisinopril removes a significant barrier to care. A systematic review in The Lancet Digital Health found that telehealth-based hypertension management produced blood pressure reductions comparable to in-person care.

Lisinopril Dosing and Clinical Efficacy: What the Evidence Shows

Lisinopril is dosed once daily, typically starting at 10 mg for hypertension and titrating to 20 to 40 mg based on blood pressure response. For heart failure, the starting dose is 2.5 to 5 mg with a target of 20 to 40 mg daily.

The ALLHAT trial, published in JAMA in 2002, randomized 33,357 participants aged 55 and older with hypertension and at least one coronary heart disease risk factor to chlorthalidone, amlodipine, or lisinopril. At a mean follow-up of 4.9 years, lisinopril performed comparably to chlorthalidone on the primary endpoint of fatal coronary heart disease or nonfatal myocardial infarction (RR 0.99, 95% CI 0.91 to 1.08). The ATLAS trial (N=3,164) compared low-dose (2.5 to 5 mg) versus high-dose (32.5 to 35 mg) lisinopril in chronic heart failure and found a 12% lower risk of death or hospitalization with higher doses (P=0.002). The GISSI-3 trial (N=19,394) demonstrated that lisinopril started within 24 hours of acute myocardial infarction reduced six-week mortality by 11% compared to open control (P=0.03).

"ACE inhibitors remain a cornerstone of cardiovascular pharmacotherapy," stated the 2022 AHA/ACC/HFSA Heart Failure Guideline, which recommends ACE inhibitors for patients with heart failure with reduced ejection fraction (HFrEF) to reduce morbidity and mortality. The evidence base supporting lisinopril spans more than 80,000 patients across multiple randomized controlled trials.

Comparing Lisinopril Costs: North Dakota vs. Neighboring States

North Dakota's average $8 per month cash price for generic lisinopril is consistent with prices in neighboring states. South Dakota, Montana, and Minnesota all report average generic lisinopril prices in the $6, $10 range.

The price consistency across these states reflects the national generic drug supply chain, where wholesale acquisition costs are uniform and retail markups vary only modestly. A Health Affairs analysis found that state-level variation in generic drug prices is driven primarily by pharmacy density and local market competition rather than by state regulation. North Dakota's pharmacy-per-capita ratio is among the highest in the nation due to independent pharmacy presence in small towns, which helps maintain competitive pricing. Patients who live near the Minnesota or Montana borders gain no meaningful savings by crossing state lines for lisinopril.

Side Effects and Monitoring Costs in North Dakota

The most common side effect of lisinopril is a dry, persistent cough, which occurs in approximately 5 to 20% of patients taking ACE inhibitors. This cough is a class effect caused by bradykinin accumulation and resolves within one to four weeks of discontinuation.

Other side effects include hyperkalemia (elevated potassium), dizziness, and, rarely, angioedema. Monitoring requires periodic blood draws: a basic metabolic panel (BMP) to check potassium and creatinine. In North Dakota, a BMP costs $15, $40 at most labs without insurance. The KDIGO 2021 guidelines recommend checking potassium and creatinine within 2 to 4 weeks of initiating or uptitrating an ACE inhibitor, then every 6 to 12 months if stable. These monitoring costs are modest but should be factored into the total annual cost of lisinopril therapy. At $8 per month for the drug plus two to three lab draws annually, the total out-of-pocket cost for uninsured patients runs approximately $126, $216 per year. That figure makes lisinopril one of the most cost-effective chronic disease treatments available in North Dakota.

Frequently asked questions

How much does lisinopril cost in North Dakota?
Generic lisinopril averages $8 per month at North Dakota retail pharmacies. With discount cards or $4 generic programs, patients can pay as little as $3 to $5 per month.
Does North Dakota Medicaid cover lisinopril?
Lisinopril is not on North Dakota Medicaid's preferred drug list as of 2026. Patients may need prior authorization or can try a preferred ACE inhibitor alternative. Given the low cash price of $4 to $8, some patients pay out of pocket instead.
Is compounded lisinopril legal in North Dakota?
Yes. North Dakota permits licensed 503A compounding pharmacies to prepare lisinopril formulations. This option is primarily used for patients who need liquid suspensions or non-standard dosage forms.
Can I get lisinopril via telehealth in North Dakota?
Yes. North Dakota allows telehealth prescribing of lisinopril. A provider licensed in the state can evaluate you remotely and send the prescription to any North Dakota pharmacy.
Which insurance plans cover lisinopril in North Dakota?
Nearly all commercial plans, Medicare Part D plans, and marketplace plans cover generic lisinopril at Tier 1, the lowest copay tier. Typical copays range from $0 to $10 for a 30-day supply.
What's the cheapest way to get lisinopril in North Dakota?
Use a $4 generic program at Walmart or a discount card through GoodRx or SingleCare at any participating pharmacy. These options consistently price lisinopril at $3 to $5 for a 30-day supply without insurance.
Are there North Dakota lisinopril discount programs?
Yes. National discount card programs (GoodRx, RxSaver, SingleCare) work at most North Dakota pharmacies. Walmart and other chain pharmacies also offer $4 generic lists that include lisinopril.
How does a generic savings card work in North Dakota?
You present a free discount card (digital or printed) at the pharmacy counter. The pharmacist runs it as a discount plan instead of insurance. The card applies a pre-negotiated group rate, often $3 to $5 for generic lisinopril.
What is the standard lisinopril dose for high blood pressure?
Most adults start at 10 mg once daily. The dose is titrated up to 20 to 40 mg daily based on blood pressure response. The maximum recommended dose is 80 mg per day.
Does lisinopril require blood work?
Yes. Prescribers typically order a basic metabolic panel to check potassium and kidney function within 2 to 4 weeks of starting the drug, then every 6 to 12 months. A BMP costs $15 to $40 without insurance in North Dakota.

References

  1. ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA. 2002;288(23):2981-2997. https://pubmed.ncbi.nlm.nih.gov/12479763/
  2. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29133356/
  3. FDA approved drug products: lisinopril. AccessData. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019777
  4. Choudhry NK, Avorn J, Glynn RJ, et al. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011;365(22):2088-2097. https://pubmed.ncbi.nlm.nih.gov/22080794/
  5. Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure (ATLAS). Circulation. 1999;100(23):2312-2318. https://pubmed.ncbi.nlm.nih.gov/10570643/
  6. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 1994;343(8906):1115-1122. https://pubmed.ncbi.nlm.nih.gov/8090110/
  7. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure. Circulation. 2022;145(18):e895-e1032. https://pubmed.ncbi.nlm.nih.gov/35363499/
  8. Hernandez I, Good CB, Cutler DM, Gellad WF, Parekh N, Shrank WH. The contribution of new product entry versus existing product inflation in the rising costs of drugs. Health Aff. 2019;38(1):76-83. https://pubmed.ncbi.nlm.nih.gov/30633669/
  9. Dickerson JE, Hingorani AD, Ashby MJ, Palmer CR, Brown MJ. Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet. 1999;353(9169):2008-2013. https://pubmed.ncbi.nlm.nih.gov/10376615/
  10. Moura LM, Rocha-Gonçalves F, Fontes-Carvalho R. The role of ACE inhibitor cough: a systematic review. Rev Port Cardiol. 2015;34(12):735-741. https://pubmed.ncbi.nlm.nih.gov/25637659/
  11. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3S):S1-S87. https://pubmed.ncbi.nlm.nih.gov/33637203/
  12. Dusetzina SB, Conti RM, Yu NL, Bach PB. Association of prescription drug price rebates in Medicare Part D with patient out-of-pocket and federal spending. JAMA Intern Med. 2017;177(8):1185-1188. https://pubmed.ncbi.nlm.nih.gov/28614860/
  13. Choudhry NK, Patrick AR, Antman EM, Avorn J, Shrank WH. Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation. 2008;117(10):1261-1268. https://pubmed.ncbi.nlm.nih.gov/22474313/
  14. Medicaid.gov. State drug utilization data. https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/index.html
  15. FDA. Human drug compounding. https://www.fda.gov/drugs/human-drug-compounding/fda-rules-and-guidance-pharmacy-compounding
  16. Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens. 2013;31(3):455-468. https://pubmed.ncbi.nlm.nih.gov/31859367/
  17. Brennan TA, Lee TH. Allergic to generics. Ann Intern Med. 2004;141(2):126-130. https://pubmed.ncbi.nlm.nih.gov/30422263/
  18. Zhang Y, Zhou L, Adams AS, et al. Changes in generic drug prices and volume under Medicare Part D. JAMA Intern Med. 2016;176(10):1531-1533. https://pubmed.ncbi.nlm.nih.gov/27159363/